Chemed Corporation $CHE Stock Position Trimmed by Quantinno Capital Management LP

Quantinno Capital Management LP trimmed its position in shares of Chemed Corporation (NYSE:CHE) by 55.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,603 shares of the company’s stock after selling 8,251 shares during the period. Quantinno Capital Management LP’s holdings in Chemed were worth $2,494,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Lazard Asset Management LLC raised its holdings in shares of Chemed by 3.1% during the first quarter. Lazard Asset Management LLC now owns 7,389 shares of the company’s stock valued at $2,791,000 after buying an additional 225 shares during the last quarter. Entropy Technologies LP grew its holdings in Chemed by 491.7% in the 1st quarter. Entropy Technologies LP now owns 7,195 shares of the company’s stock worth $2,718,000 after buying an additional 5,979 shares in the last quarter. Morningstar Investment Management LLC increased its position in Chemed by 42.6% in the 1st quarter. Morningstar Investment Management LLC now owns 1,231 shares of the company’s stock valued at $465,000 after acquiring an additional 368 shares during the period. Inceptionr LLC acquired a new stake in Chemed in the 1st quarter valued at approximately $263,000. Finally, Bank of Nova Scotia raised its stake in Chemed by 94.7% during the 1st quarter. Bank of Nova Scotia now owns 21,844 shares of the company’s stock valued at $8,251,000 after acquiring an additional 10,622 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This trade represents a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 3,537 shares of company stock worth $1,782,654. 3.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada increased their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Oppenheimer raised their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research note on Friday, July 31st. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $530.75.

Chemed Trading Down 0.1%

Shares of CHE stock opened at $552.28 on Monday. The stock has a 50-day simple moving average of $477.97 and a 200 day simple moving average of $439.75. The stock has a market capitalization of $7.22 billion, a P/E ratio of 27.74, a P/E/G ratio of 2.09 and a beta of 0.51. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $553.00. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same period in the previous year, the business earned $4.27 earnings per share. Chemed’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, sell-side analysts expect that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 0.5%. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. Chemed’s dividend payout ratio (DPR) is presently 12.05%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.